Vascular Access in Patients With Peripheral Arterial Disease Undergoing TAVR

被引：27

作者：

Palmerini, Tullio ^{[1
,2
,36
]}

Saia, Francesco ^{[1
,2
]}

Kim, Won-Keun ^{[3
]}

Renker, Matthias ^{[3
]}

Iadanza, Alessandro ^{[4
]}

Fineschi, Massimo ^{[4
]}

Bruno, Antonio Giulio ^{[1
,2
]}

Ghetti, Gabriele ^{[1
,2
]}

Vanhaverbeke, Maarten ^{[5
]}

Sondergaard, Lars ^{[5
]}

De Backer, Ole ^{[5
]}

Romagnoli, Enrico ^{[6
]}

Burzotta, Francesco ^{[1
,6
]}

Trani, Carlo ^{[1
,6
]}

Adrichem, Rik ^{[7
]}

Van Mieghem, Nicolas M. ^{[7
]}

Nardi, Elena ^{[1
]}

Chietera, Francesco ^{[1
,2
]}

Orzalkiewicz, Mateusz ^{[1
,2
]}

Tomii, Daijiro ^{[8
]}

Pilgrim, Thomas ^{[8
]}

Aranzulla, Tiziana Claudia ^{[9
]}

Musumeci, Giuseppe ^{[9
]}

Adam, Matti ^{[10
]}

Meertens, Max M. ^{[10
]}

Taglieri, Nevio ^{[1
,2
]}

Marrozzini, Cinzia ^{[1
,2
]}

Covarrubias, Hector Alfonso Alvarez ^{[11
,12
]}

Joner, Michael ^{[11
]}

Nardi, Giulia ^{[13
]}

Di Muro, Francesca Maria ^{[13
]}

Di Mario, Carlo ^{[13
]}

Loretz, Lucca ^{[14
]}

Toggweiler, Stefan ^{[14
]}

Gallitto, Enrico ^{[15
]}

Gargiulo, Mauro ^{[15
]}

Testa, Luca ^{[16
]}

Bedogni, Francesco ^{[16
]}

Berti, Sergio ^{[17
]}

Ancona, Marco B. ^{[18
]}

Montorfano, Matteo ^{[18
]}

Leone, Alessandro ^{[19
]}

Savini, Carlo ^{[19
]}

Pacini, Davide ^{[19
]}

Gmeiner, Jonas ^{[20
]}

Braun, Daniel ^{[20
]}

Nerla, Roberto ^{[21
]}

Castriota, Fausto ^{[21
]}

De Carlo, Marco ^{[22
]}

Petronio, Anna Sonia ^{[22
]}

机构：

[1] IRCCS Azienda Osped Univ Bologna, Cardiac Thorac & Vasc Dept, Cardiol Unit, Bologna, Italy

[2] Univ Bologna, Cardiac Thorac & Vasc Dept, Bologna, Italy

[3] Kerckhoff Heart Ctr, Bad Nauheim, Germany

[4] Azienda Osped Univ Senese, UOSA Cardiol Interventist, Siena, Italy

[5] Copenhagen Univ Hosp, Heart Ctr, Rigshosp, Copenhagen, Denmark

[6] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Agostino Gemelli IRCCS, UOC Interventist Cardiol & Diagnost Invas, Rome, Italy

[7] Erasmus MC, Dept Cardiol, Thoraxctr, Rotterdam, Netherlands

[8] Univ Bern, Bern Univ Hosp, Inselspital, Bern, Switzerland

[9] AO Mauriziano Umberto I Hosp, Turin, Italy

[10] Univ Hosp Cologne, Heart Ctr, Klin Innere Med Kardiol Pneumol & Internist Intens, Cologne, Germany

[11] German Heart Ctr Munich, Munich, Germany

[12] Inst Mexicano Seguro Social, Hosp Cardiol, Ctr Med Nacl Siglo 21, Mexico City, Mexico

[13] Univ Hosp Careggi, Florence, Italy

[14] Heart Ctr Lucerne, Cardiol, Luzern, Switzerland

[15] IRCCS Azienda Osped Univ Bologna, Dipartimento Med Specialist Diagnost & Sperimental, Vasc Surg, Bologna, Italy

[16] IRCCS Policlin S Donato, Coronary Revascularisat Unit, San Donato Milanese, Italy

[17] Osped Cuore, Unit Diagnost & Intervent Cardiol, CNR Reg Toscana G Monasterio Fdn, Massa, Italy

[18] IRCCS San Raffaele Scienti f Inst, Intervent Cardiol Unit, Milan, Italy

[19] IRCCS Azienda Osped Univ Bologna, Cardiac Thorac & Vasc Dept, Cardiac Surg Unit, Bologna, Italy

[20] Ludwig Maximilian Univ Munich, Univ Hosp Munich, Med Fac, Dept Med 1, Munich, Germany

[21] Cardioangiol Cath Lab, Cotignola, Italy

[22] Pisa Univ Hosp, Cardiothorac & Vasc Dept, Pisa, Italy

[23] Univ Catania, Policlin Vittorio Emanuele Hosp, Div Cardiol, Catania, Italy

[24] Humanitas Res Hosp IRCCS, Cardio Ctr, Rozzano, Italy

[25] Univ Klinikum Bonn, Med Klin & Poliklin 2, Herzzentrum Bonn, Bonn, Germany

[26] Azienda Osped Univ, Osped Riuniti Umberto 1 GM Lancisi, Torette, Italy

[27] Albert Einstein Coll Med, Montefiore Med Ctr, Montefiore Einstein Ctr Heart & Vasc Care, Bronx, NY USA

[28] Cardiovasc Res Fdn, New York, NY USA

[29] IRCCS Osped Policlin San Martino, Cardiothoraco Vasc Dept, Cardiol Unit, Genoa, Italy

[30] Rabin Med Ctr, Petah Tiqwa, Israel

[31] Ctr Cardiol Monzino, Milan, Italy

[32] Univ Milan, Dept Biomed & Clin Sci, Milan, Italy

[33] Univ Padua, Dept Cardiac Thorac & Vasc Sci, Padua, Italy

[34] Univ Leipzig, Heart Ctr Leipzig, Leipzig, Germany

[35] Icahn Sch Med Mt Sinai, Zena & Michael A Wiener Cardiovasc Inst, New York, NY USA

[36] IRCCS Azienda Osped Univ Bologna, Via Massarenti 9, I-40138 Bologna, Italy

来源：

JACC-CARDIOVASCULAR INTERVENTIONS | 2023年 / 16卷 / 04期

关键词：

alternative access; critical patient; femoral access; transcatheter aortic valve replacement; AORTIC-VALVE-REPLACEMENT; SUBCLAVIAN/AXILLARY ACCESS; ALTERNATIVE ACCESS; TVT REGISTRY; OUTCOMES; IMPLANTATION; STENOSIS;

D O I：

10.1016/j.jcin.2022.12.009

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

BACKGROUND The optimal access route in patients with severe peripheral artery disease (PAD) undergoing transcatheter aortic valve replacement (TAVR) remains undetermined. OBJECTIVES This study sought to compare clinical outcomes with transfemoral access (TFA), transthoracic access (TTA), and nonthoracic transalternative access (TAA) in TAVR patients with severe PAD. METHODS Patients with PAD and hostile femoral access (TFA impossible, or possible only after percutaneous treatment) undergoing TAVR at 28 international centers were included in this registry. The primary endpoint was the propensity-adjusted risk of 30-day major adverse events (MAE) defined as the composite of all-cause mortality, stroke/transient ischemic attack (TIA), or main access site-related Valve Academic Research Con-sortium 3 major vascular complications. Outcomes were also stratified according to the severity of PAD using a novel risk score (Hostile score). RESULTS Among the 1,707 patients included in the registry, 518 (30.3%) underwent TAVR with TFA after percutaneous treatment, 642 (37.6%) with TTA, and 547 (32.0%) with TAA (mostly transaxillary). Compared with TTA, both TFA (adjusted HR: 0.58; 95% CI: 0.45-0.75) and TAA (adjusted HR: 0.60; 95% CI: 0.47-0.78) were associated with lower 30-day rates of MAE, driven by fewer access site-related complications. Composite risks at 1 year were also lower with TFA and TAA compared with TTA. TFA compared with TAA was associated with lower 1-year risk of stroke/TIA (adjusted HR: 0.49; 95% CI: 0.24-0.98), a finding confined to patients with low Hostile scores (Pinteraction 1/4 0.049). CONCLUSIONS Among patients with PAD undergoing TAVR, both TFA and TAA were associated with lower 30-day and 1-year rates of MAE compared with TTA, but 1-year stroke/TIA rates were higher with TAA compared with TFA. (J Am Coll Cardiol Intv 2023;16:396-411) & COPY; 2023 by the American College of Cardiology Foundation.

引用

页码：396 / 411

页数：16

共 50 条

[21] Coronary artery revascularization before peripheral vascular surgery in patients with peripheral arterial disease
Miyachi, Hideki
Tanabe, Jun
Kodani, Eitaro
Hosokawa, Yusuke
Kitamura, Mitsunobu
Sasaki, Asako
Ogano, Michio
Shiiba, K.
Takagi, Hisato
Umemoto, Takuya
Kusama, Yoshiki
Mizuno, Kyoichi
CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2010, 25 (01) : 11 - 17
[22] Peripheral vascular disease risk factors among patients undergoing hemodialysis
O'Hare, AM
Hsu, CY
Bacchetti, P
Johansen, KL
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (02): : 497 - 503
[23] Transcatheter Aortic Valve Implantation in Patients With Arterial Peripheral Vascular Disease
Unzue, Leire
Garcia, Eulogio
Teijeiro, Rodrigo
Rodriguez del Rio, Miguel
Solis, Jorge
Rubio Alonsoa, Belen
REVISTA ESPANOLA DE CARDIOLOGIA, 2017, 70 (06): : 510 - +
[24] Who should treat patients with peripheral arterial disease - the vascular specialist
Sillesen, H
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2002, 24 (01) : 1 - 3
[25] PATTERN OF VASCULAR INVOLVEMENT IN PATIENTS WITH LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE
Kumar, Mukesh
Khan, Naveedullah
Jalbani, Javed
Shar, Ghulam Shabbir
Ishaq, Haroon
Shaikh, Abdul Hakeem
PAKISTAN HEART JOURNAL, 2022, 55 (02): : 166 - 170
[26] The Vascular and Biochemical Effects of Cilostazol in Diabetic Patients With Peripheral Arterial Disease
O'Donnell, Mark E.
Badger, Stephen A.
Sharif, Muhammad A.
Makar, Ragai R.
Young, Ian S.
Lee, Bernard
Soong, C. V.
VASCULAR AND ENDOVASCULAR SURGERY, 2009, 43 (02) : 132 - 143
[27] Chlamydia pneumoniae DNA in the Arterial Wall of Patients with Peripheral Vascular Disease
J. Gutiérrez
J. Linares-Palomino
C. Lopez-Espada
M. Rodríguez
E. Ros
G. Piédrola
M. del C. Maroto
Infection, 2001, 29 : 196 - 200
[28] Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease
Gutiérrez, J
Linares-Palomino, J
Lopez-Espada, C
Rodríguez, M
Ros, E
Piédrola, G
Maroto, MD
INFECTION, 2001, 29 (04) : 196 - 200
[29] Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease
Vlek, Anne L. M.
van der Graaf, Yolanda
Sluman, Maayke A.
Moll, Frans L.
Visseren, Frank L. J.
JOURNAL OF VASCULAR SURGERY, 2009, 50 (01) : 61 - 69
[30] Impact of Vessel Anatomic Complexity and Technical Failure in Patients With Severe Peripheral Artery Disease Undergoing TAVR
Romagnoli, Enrico
Burzotta, Francesco
Saia, Francesco
Kim, Won-Keun
Iadanza, Alessandro
Vanhaverbeke, Maarten
Trani, Carlo
Adrichem, Rik
Van Mieghem, Nicolas
Pilgrim, Thomas
Musumeci, Giuseppe
Adam, Matti
Joner, Michael
Di Mario, Carlo
Toggweiler, Stefan
Testa, Luca
Montorfano, Matteo
Castriota, Fausto
De Carlo, Marco
Barbanti, Marco
Reimers, Bernhard
Nickenig, Georg
Latib, Azeem
Porto, Italo
Kornowski, Ran
Tarantini, Giuseppe
Abdel-Wahab, Mohamed
Palmerini, Tullio
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B381 - B382

← 1 2 3 4 5 →